Physician profile
Danny D Cheng
NPI 1437174661
$10,735.50
in general payments reported to CMS, 2019-2025
52 companies · $1,849 in 2025
The $1,849 reported for 2025 was more than what 93% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,436 · 2020: $687 · 2021: $587 · 2022: $1,931 · 2023: $2,086 · 2024: $2,159 · 2025: $1,849.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,087 · Education: $6.65.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,087.38 |
| Education | $6.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,658.56 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Astrazeneca Pharmaceuticals LP | $1,221.26 | 2019-2025 | Farxiga, Airsupra, Breztri |
| Abbvie INC. | $948.17 | 2021-2025 | Vraylar, Qulipta, Ubrelvy |
| Amgen INC. | $895.26 | 2019-2025 | Krystexxa, Evenity, Repatha |
| Glaxosmithkline, LLC. | $784.33 | 2019-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Lilly USA, LLC | $624.96 | 2019-2025 | Jardiance, Mounjaro, Zepbound |
| Esperion Therapeutics, INC. | $503.19 | 2020-2025 | Nexletol |
| Bayer Healthcare Pharmaceuticals INC. | $467.50 | 2022-2025 | |
| Sanofi-Aventis U.S. LLC | $370.93 | 2019-2023 | |
| Janssen Pharmaceuticals, INC | $362.09 | 2019-2024 | Xarelto |
| Otsuka America Pharmaceutical, INC. | $326.17 | 2022-2025 | Rexulti |
| Amarin Pharma, INC. | $190.14 | 2019-2023 | |
| Dexcom, INC. | $188.47 | 2021-2025 | Dexcom G6 Transmitter |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $175.63 | 2020-2025 | Xifaxan, Trulance |
| Pfizer INC. | $156.67 | 2022-2025 |
Show all 52 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Idorsia Pharmaceuticals US INC | $149.94 | 2023-2024 | Quviviq |
| Boehringer Ingelheim Pharmaceuticals, INC. | $148.13 | 2019-2025 | Jardiance |
| Antares Pharma, INC. | $135.66 | 2022-2025 | Xyosted, Nocdurna, Tlando |
| Novartis Pharmaceuticals Corporation | $133.35 | 2021-2025 | |
| Abbott Laboratories | $128.57 | 2021-2024 | Freestyle Libre |
| Boston Scientific Corporation | $125.00 | 2019-2020 | |
| Exact Sciences Corporation | $87.09 | 2024-2025 | Cologuard Collection Kit |
| Azurity Pharmaceuticals, INC. | $80.78 | 2025 | Alvesco, Edarbi, Azmiro |
| Sumitomo Pharma America, INC. | $73.35 | 2024-2025 | Gemtesa |
| Astellas Pharma US INC | $62.64 | 2022-2025 | Veozah |
| Radius Health, INC. | $47.37 | 2019-2020 | |
| Kowa Pharmaceuticals America, INC. | $46.68 | 2022-2024 | Livalo |
| Corcept Therapeutics | $43.32 | 2024 | Korlym |
| Merck Sharp & Dohme LLC | $41.75 | 2022-2023 | Steglatro, Belsomra |
| Halozyme INC | $35.21 | 2023 | |
| Amneal Pharmaceuticals LLC | $32.37 | 2024-2025 | Unithroid |
| Almatica Pharma LLC | $31.91 | 2025 | Loreev Xr |
| Currax Pharmaceuticals LLC | $31.52 | 2024-2025 | Contrave |
| Ibsa Pharma INC. | $31.48 | 2022-2025 | Tirosint, Licart, Flector |
| Vanda Pharmaceuticals INC. | $30.45 | 2021 | |
| Scilex Pharmaceuticals INC. | $30.32 | 2023 | Ztlido |
| Lundbeck LLC | $28.82 | 2025 | Rexulti |
| Verity Pharmaceuticals INC. | $28.50 | 2024 | Tlando |
| Kyowa Kirin, INC. | $28.27 | 2025 | |
| Tolmar, INC. | $26.21 | 2025 | Jatenzo |
| Medtronic, INC. | $25.00 | 2021 | |
| Inspire Medical Systems, INC. | $24.89 | 2024 | Inspire |
| Nestle Healthcare Nutrition INC. | $23.21 | 2022 | |
| Eisai INC. | $22.90 | 2022 | |
| Hologic Sales and Service, LLC | $22.69 | 2024 | Thinprep 2000 Processor, Aptima |
| Takeda Pharmaceuticals U.S.A., INC. | $17.50 | 2019 | |
| Philips North America LLC | $17.49 | 2023 | |
| Teva Pharmaceuticals USA, INC. | $16.13 | 2019 | |
| Genentech USA, INC. | $14.00 | 2019 | |
| Allergan, INC. | $14.00 | 2019 | |
| Sanofi Pasteur INC. | $14.00 | 2020 | |
| Optinose US, INC. | $11.67 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Danny Cheng listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.